First, among the 22 angiogenesis-related proteins analyzed, ANGPTL4, ANGPTL3, and endostatin were the only ones that were significantly elevated in PAD patients who experienced 2-year MACEs compared to those who did not. The gene discussed is COL18A1; the disease is peripheral arterial disease.